Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Furberg

Showing results (101-110 of 205) with videos related to

Pageof 21
Sort By:
The American Journal of Cardiology|October 1, 1984
Assessment of quality of life in clinical trials of cardiovascular therapiesN K Wenger, M E Mattson, C D Furberg, et al.
Annals of Internal Medicine|December 19, 2001
Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of HypertensionC D Furberg, B M Psaty, M Pahor, et al.
Journal of Clinical Pharmacy and Therapeutics|August 9, 2001
Isoprostane 8-epi-PGF2alpha is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapyH Sinzinger, G Lupattelli, F Chehne, et al.
Progress in Cardiovascular Diseases|November 1, 1986
The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trialsS W MacMahon, J A Cutler, C D Furberg, et al.
Progress in Cardiovascular Diseases|January 1, 1983
Secondary prevention after myocardial infarction: a review of short-term acute phase trialsG S May, C D Furberg, K A Eberlein, et al.
Archives of Internal Medicine|November 1, 1992
Lack of age-related differences in the clinical presentation of digoxin toxicityJ L Wofford, A R Hickey, W H Ettinger, et al.
Lancet (London, England)|April 20, 1996
Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years oldM Pahor, J M Guralnik, C D Furberg, et al.
Journal of Internal Medicine|November 1, 1994
Quality control in ultrasound studies on atherosclerosisG L Berglund, W A Riley, R W Barnes, et al.
Archives of Internal Medicine|June 23, 1997
Reductase inhibitor monotherapy and stroke preventionJ R Crouse, R P Byington, H M Hoen, et al.
The American Journal of Cardiology|June 1, 1994
Pravastatin, lipids, and major coronary eventsC D Furberg, R P Byington, J R Crouse, et al.
Pageof 21

Showing results (101-110 of 205) with videos related to

Sort By:
Pageof 21
The American Journal of Cardiology|October 1, 1984
Assessment of quality of life in clinical trials of cardiovascular therapiesN K Wenger, M E Mattson, C D Furberg, et al.
Annals of Internal Medicine|December 19, 2001
Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of HypertensionC D Furberg, B M Psaty, M Pahor, et al.
Journal of Clinical Pharmacy and Therapeutics|August 9, 2001
Isoprostane 8-epi-PGF2alpha is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapyH Sinzinger, G Lupattelli, F Chehne, et al.
Progress in Cardiovascular Diseases|November 1, 1986
The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trialsS W MacMahon, J A Cutler, C D Furberg, et al.
Progress in Cardiovascular Diseases|January 1, 1983
Secondary prevention after myocardial infarction: a review of short-term acute phase trialsG S May, C D Furberg, K A Eberlein, et al.
Archives of Internal Medicine|November 1, 1992
Lack of age-related differences in the clinical presentation of digoxin toxicityJ L Wofford, A R Hickey, W H Ettinger, et al.
Lancet (London, England)|April 20, 1996
Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years oldM Pahor, J M Guralnik, C D Furberg, et al.
Journal of Internal Medicine|November 1, 1994
Quality control in ultrasound studies on atherosclerosisG L Berglund, W A Riley, R W Barnes, et al.
Archives of Internal Medicine|June 23, 1997
Reductase inhibitor monotherapy and stroke preventionJ R Crouse, R P Byington, H M Hoen, et al.
The American Journal of Cardiology|June 1, 1994
Pravastatin, lipids, and major coronary eventsC D Furberg, R P Byington, J R Crouse, et al.
Pageof 21